汇添富中证中药ETF(560080)利润分配表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
收入 |
-88,978,497.55 |
-221,647,392.54 |
5,435,895.98 |
227,500,460.46 |
利息合计 |
928,954.63 |
897,092.66 |
2,385,775.23 |
1,131,296.43 |
其中:存款利息收入 |
69,608.23 |
37,746.26 |
88,633.71 |
51,575.43 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益合计 |
-106,989,263.75 |
-70,228,554.45 |
-26,411,528.10 |
34,415,093.29 |
其中:股票投资收益 |
-167,158,871.85 |
-105,068,934.25 |
-62,037,953.27 |
9,401,847.61 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
- |
- |
- |
- |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
60,169,608.10 |
34,840,379.80 |
35,626,425.17 |
25,013,245.68 |
基金分红收益收益 |
- |
- |
- |
- |
公允价值变动收益 |
16,174,717.31 |
-153,265,829.28 |
26,428,320.33 |
190,138,030.27 |
其他收入 |
907,094.26 |
949,898.53 |
3,033,328.52 |
1,816,040.47 |
费用 |
12,027,874.38 |
5,765,788.54 |
12,697,327.04 |
6,339,948.10 |
管理人报酬 |
9,866,621.07 |
4,721,622.63 |
10,430,995.50 |
5,208,719.35 |
基金托管费 |
1,973,324.13 |
944,324.53 |
2,086,199.07 |
1,041,743.89 |
销售服务费 |
- |
- |
- |
- |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
184,835.26 |
96,747.46 |
171,861.47 |
85,597.49 |
利润总额 |
-101,006,371.93 |
-227,413,181.08 |
-7,261,431.06 |
221,160,512.36 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年